Clinical Trial Update: Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated a single dose of Menactra given 4-6 years after prior Menactra vaccination; the trial is completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Infection

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Infection | Phase 2 | Status: COMPLETED | Results posted: 2014-11-18